Angela Kashuba
Angela Kashuba is a renowned pharmacologist and academic, known for her significant contributions to the field of pharmacology. She is currently serving as the Dean of the University of North Carolina Eshelman School of Pharmacy.
Early Life and Education[edit | edit source]
Angela Kashuba was born and raised in Canada. She completed her Bachelor of Science degree in Pharmacy from the University of Saskatchewan. She then moved to the United States to pursue her Doctor of Pharmacy degree from the State University of New York at Buffalo. Kashuba furthered her education by completing a postdoctoral fellowship in Clinical Pharmacology at the University of California, San Francisco.
Career[edit | edit source]
Kashuba started her career as a faculty member at the University of North Carolina (UNC) in 1997. She has since held various positions at the university, including the John and Deborah McNeill Distinguished Professor, and the Director of the UNC Center for AIDS Research Clinical Pharmacology and Analytical Chemistry Core.
In 2019, Kashuba was appointed as the Dean of the UNC Eshelman School of Pharmacy, becoming the first woman to hold this position. Her research primarily focuses on antiretroviral therapy and the treatment of HIV/AIDS.
Research[edit | edit source]
Kashuba's research has significantly contributed to the understanding of antiretroviral drugs and their impact on HIV treatment. Her work has helped in the development of effective strategies for HIV prevention and treatment. She has published numerous research articles in reputed scientific journals and has been a part of various national and international scientific committees.
Awards and Recognition[edit | edit source]
Throughout her career, Kashuba has received numerous awards and recognitions for her contributions to the field of pharmacology. These include the Leon I Goldberg Young Investigator Award from the American Society for Clinical Pharmacology and Therapeutics, and the Paul Ehrlich Magic Bullet Lifetime Achievement Award from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
See Also[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
